non-muscle invasive bladder
Conditions
Interventions
Long-Term Antiplatelet Therapy Group:None
Non-Antiplatelet Therapy Group:None
Sponsors
Jing'an District Central Hospital Of Shanghai
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Diagnosis of non-muscle invasive bladder cancer (Ta, T1); 2. Exposure group: long-term aspirin and/or clopidogrel use for >=7 days; The control group did not take any anti-platelet aggregation drugs within six months before surgery; 3. Age >=18 years old; 4. Complete clinical data; 5. Informed consent was obtained; 6. Transurethral thulium laser resection of bladder tumor was performed.
Exclusion criteria
Exclusion criteria: 1. Muscle-invasive bladder cancer (T2 and above); 2. Combined with other malignant tumors; 3. There was severe coagulopathy before surgery; 4. Renal failure requiring dialysis; 5. Pregnant or lactating women; 6. Patients with incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin(g/l); | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of severe bleeding within one month after the operation.;The incidence rate of severe cardiovascular and cerebrovascular events during the perioperative period;Incidence of severe intraoperative bleeding;The rate of readmission within one month after surgery; | — |
Countries
China
Contacts
Public ContactJiling Wen
Jing'an District Central Hospital Of Shanghai
Outcome results
None listed